We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BELL market cap is 15.58M. The company's latest EPS is USD -0.1100 and P/E is -0.84.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 129k | 0 | 420k | 1.54M | 825k |
| Operating Income | -1.18M | -1.55M | -5.92M | -11.01M | -12.3M |
| Net Income | -1.55M | -1.98M | -5.21M | -8.15M | -18.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.53M | 5.24M | 26.01M | 23.6M | 20.82M |
| Total Liabilities | 802k | 568k | 1.33M | 3.25M | 3.13M |
| Total Equity | 3.73M | 4.67M | 24.67M | 20.35M | 17.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1M | -1.47M | -6.99M | -14.91M | -9.13M |
| Investing | -1.08M | -1.19M | -2.8M | -5.08M | -4.53M |
| Financing | 2.55M | 2.13M | 25.36M | 7.29M | 12.51M |
| Market Cap | 15.58M |
| Price to Earnings Ratio | -0.84 |
| Price to Sales Ratio | 18.88 |
| Price to Cash Ratio | 16.82 |
| Price to Book Ratio | 0.88 |
| Dividend Yield | - |
| Shares Outstanding | 168.41M |
| Average Volume (1 week) | 206.09k |
| Average Volume (1 Month) | 123.67k |
| 52 Week Change | -48.61% |
| 52 Week High | 25.50 |
| 52 Week Low | 7.25 |
| Spread (Intraday) | 1.5 (15%) |
| Company Name | Belluscura Plc |
| Address |
15 fetter lane london EC4A 1BW |
| Website | https://www.belluscura.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
